A new study has revealed that protein-hydrolyzed lactose-free milk is better tolerated by lactose-intolerant individuals than A2 milk which is marketed as a gut-friendly alternative.
A recent Finnish study investigated the effects of A2 milk, marketed as a gut-friendly alternative, and protein-hydrolyzed lactose-free milk on gastrointestinal symptoms and inflammation levels.
(Source: University of Turku)
Turku/Finland – A recent Finnish study investigated the effects of A2 milk, marketed as a gut-friendly alternative, and protein-hydrolyzed lactose-free milk on gastrointestinal symptoms and inflammation levels. The study found that protein-hydrolyzed lactose-free milk was as tolerated as A2 milk by lactose-tolerant individuals and better tolerated by lactose-intolerant individuals.
Turku/Finland – The best-known cause of milk-induced gastrointestinal symptoms is lactose intolerance, which is an inability to digest lactose, a sugar found in dairy products. However, many people experience gut symptoms when ingesting milk and avoid dairy products even though they are lactose-tolerant according to their genotype.
Cow's milk products sold in Finland typically contain both A1 and A2 beta-casein proteins. However, some cows naturally produce only A2 beta-casein, and their milk has long been available globally as a separate product. This A2 milk is marketed as a gut-friendly alternative to regular A1A2 milk, even though previous research on the symptoms caused by A2 milk has, for example, neglected the role of lactose as a cause of symptoms.
In addition to the lactose content and the type of beta-casein in the milk, the partial break down of milk proteins during processing called hydrolysis can affect how the gut reacts to milk.
A recent clinical study conducted at the Food Sciences Unit of the University of Turku in Finland investigated the effects of A2 milk and protein-hydrolyzed lactose-free A1A2 milk on gastrointestinal symptoms and inflammation in people who experience gut symptoms from milk. In the study, lactose-tolerant and lactose-intolerant participants were divided into two groups, and the symptoms of each group were monitored separately during the trial periods of the different milk alternatives.
Least stomach symptoms were observed with lactose-free protein hydrolyzed A1A2 milk
The results of the study show that breaking down milk proteins is a promising method for people who are sensitive to milk, as A2 milk and protein-hydrolyzed A1A2 milk caused equally less stomach symptoms for lactose-tolerant individuals. In contrast, lactose-intolerant participants had a clear increase in gut symptoms when the lactose content in the milk increased.
“Of the milks investigated in our study, the lactose-free, protein-hydrolyzed A1A2 milk was the best milk choice for lactose-intolerant people, and it was at least as stomach-friendly as A2 milk for those who can tolerate lactose," says Principal Investigator Kaisa Linderborg, Professor of Molecular Food Sciences at the University of Turku.
However, some participants got gastrointestinal symptoms from all types of milk, and also during the research period when they were
entirely without dairy products. The researchers found no differences in inflammatory markers, such as high-sensitivity CRP and faecal calprotectin, between the dairy-free diets and the different milks. In addition, no significant changes were observed in the levels of individual cytokines.
“This was the third study conducted in our unit on milk-related gastrointestinal symptoms. We found the same challenge as with the previous studies, namely that milk is not the only cause of gut symptoms, but that there are usually also other factors behind them. This time, however, the genotyping of the participants by lactase enzyme and the partial protein hydrolysis added novelty to the study," says Linderborg.
The study had 36 participants. Participants were divided into two groups based on their lactase enzyme genotype, which allowed the researchers to study the groups according to their lactose tolerance. The study was conducted as a randomized, three-leg, crossover trial, with participants completing all the study periods in a random order. The participants started with a wash-out of milk-free week for baseline measurements, and continued with study periods of consuming regular A2 milk, A2 milk with lactase enzyme, and lactose-free protein hydrolyzed A1A2 milk. In the study, the researchers examined gastrointestinal symptoms, faecal calprotectin, and plasma inflammation markers.
During the study periods, the participants avoided other dairy products and gave blood and stool samples after each period. “We would have liked to include, for example, a lactose-containing A1A2 milk and a dairy-free option as controls, but it was not possible this time. In such long nutrition studies, participants must be highly motivated to complete the study,” says Professor Linderborg.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
The lack of an answer to the symptoms of lactose-tolerant participants indicates a great diversity in the cause and experience of gut symptoms. The results highlight the importance of individual lactose tolerance and suggest that gut symptoms may be caused by several factors, even if they are perceived to be caused by a single food group. The study provides new insights into the source of diet-induced gastrointestinal symptoms and may help in the development of dairy products for sensitive consumers.
“Milk and milk products are nutritionally and culturally major components of the Western diet, so it is important to continue to study their impact on gastrointestinal symptoms," Linderborg concludes.
The study was funded by the University of Turku, the Foundation for Nutrition Research and Valio Ltd. Valio donated protein-hydrolyzed lactose-free milk for the research and analyzed the composition of the different study milks. Valio was not involved in the analysis or interpretation of the research results.
The results were published in September in the peer-reviewed Journal of Dairy Science.